MOLECULAR BASIS OF ENDOMETRIOSI
Abstract
BACKGROUND Endometriosis is defined as the presence of endometrial glands and stroma within extrauterine sites. Estimations show that up to 15 % of women in their reproductive age areaffected. Extrauterine endometrial tissue can be found on the pelvic peritoneum, on theovaries, in the rectovaginal septum, and more rarely, in the pericardium and pleura forming three different entities: peritoneal endometriosis, ovarian endometriosis and deependometriotic nodules of the rectovaginal septum. Symptoms for endometriosis may include painful and/or heavy periods, pain during intercourse, pelvic pain, 30–50 % reducedfertility and low back pain. Pathogenesis of endometriosis is not yet fully understood. It iswell known that endometriosis is an estrogen-dependent disease, with distinctive genetic,immunological and environmental risk factors. CONCLUSIONS The review focuses on different cell processes which are disturbed in endometriosis patients. A better understanding of the molecular basis of endometriosis will aid in identification of molecular markers and novel drug targets in the future, providing better diagnostics and treatmentDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
